J. Lennerstrand et al., APPLICATION OF A CHAIN TERMINATION ASSAY FOR CHARACTERIZATION OF REVERSE-TRANSCRIPTASE FROM AZT-RESISTANT HIV ISOLATES, Antiviral chemistry & chemotherapy, 7(6), 1996, pp. 313-320
An enzymatic assay based on utilization of one primer/enzyme molecule
was specifically designed for evaluation of the chain termination capa
city of reverse transcriptase (RT) from HIV-1 isolates. In this assay
system (CT assay) there was a 3.2-fold difference between the AZT-trip
hosphate (AZT-TP) concentrations required to terminate 50% of the prim
ers (TC50) for a highly resistant isolate, carrying the four common mu
tations at positions 67, 70, 215, and 219; and two wild type isolates.
Two of three other isolates with reduced sensitivity to AZT in cell c
ulture exhibited intermediate values in CT assay, while one behaved as
the wild type isolates. There was a correlation P = 0.05 (r = 0.86, n
= 6) between the ED(50) values found in cell culture and the TC50 val
ues found in CT assay. This relationship was not found in a similar as
say system which measured competition between AZT-TP and 1 mu M tymidi
ne triphosphate (TTP) at the enzymatic level. The sequence data of the
current isolates gave some information concerning which mutations in
the RT gene specifically affect the enzymatic properties measured in C
T assay. Mutation only at amino acid 70 had no effect, but the TC50 va
lues found increased with accumulation of the other common AZT resista
nce mutations.